{
    "SPADE_UN_12122": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12122",
            "Peptide Name": "NBC2254 (De Novo Synthesis)",
            "Source": "synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "CALKLTKAKRLVRKIGF",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.31119600] Gram-positive bacteria:MRSA(MIC=73 ± 0.02µM);Gram-negative bacteria:Escherichia coli O157:H7(MIC=3.5 ± 0.05µM)",
            "Hemolytic Activity": "[Ref.31119600] No hemolytic activity against bovine blood cells",
            "Cytotoxicity": "[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2254 is 93.7%, 90.1%, 89.5%, 95.9% and 78.6% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C89H161N27O19S",
            "Mass": 1945.47,
            "PI": 11.17,
            "Net Charge": 6,
            "Hydrophobicity": 0.19,
            "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.",
            "Literature": [
                {
                    "Title": "New Synthetic Peptides Conjugated to Gold Nanoclusters Antibiotic Activity Against Escherichia coli O157H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).",
                    "Pubmed ID": "31119600",
                    "Reference": "Protein J. 2019 May 22. doi 10.1007/s10930-019-09840-9.",
                    "Author": "Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31119600"
                },
                {
                    "Title": "new Synthetic Peptides Conjugated to Gold nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA)",
                    "Pubmed ID": "",
                    "Author": "Prada YA, Guzm��n F, Ortiz C, Cabanzo R, Torres R, Mejia-Ospino E"
                }
            ],
            "Frequent Amino Acids": "KLA",
            "Absent Amino Acids": "DEHMNOPQSUWY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 11,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00709",
                    "Similarity": 0.8571428571428571,
                    "Sequence": "KLFKKIGIGAVLKVLTTGLPALKLTK"
                },
                {
                    "SPADE_ID": "SPADE_UN_00711",
                    "Similarity": 0.8571428571428571,
                    "Sequence": "KLWKLFKKIGIGAVLKVLTTGLPALKLTK"
                },
                {
                    "SPADE_ID": "SPADE_UN_00783",
                    "Similarity": 0.8571428571428571,
                    "Sequence": "KWKLFKKIGIGAVLKVLTPGLPALKLTK"
                }
            ]
        }
    }
}